Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors
Gerald S. Falchook, Karthik Venkatakrishnan, John Sarantopoulos, Razelle Kurzrock, Alain C. Mita, Siqing Fu, Monica M. Mita, Xiaofei Zhou, Jung Ah Jung, Claudio Dansky Ullmann, Catherine Milch, Lee S. Rosen
Dive into the research topics of 'Relative bioavailability of a prototype oral solution of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with advanced solid tumors'. Together they form a unique fingerprint.